These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16731840)

  • 1. Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes.
    Kishore P; Tonelli J; Koppaka S; Fratila C; Bose A; Lee DE; Reddy K; Hawkins M
    Diabetes; 2006 Jun; 55(6):1761-8. PubMed ID: 16731840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study.
    Horvath K; Bock G; Regittnig W; Bodenlenz M; Wutte A; Plank J; Magnes C; Sinner F; Fürst-Recktenwald S; Theobald K; Pieber TR
    Diabetes Obes Metab; 2008 Jun; 10(6):484-91. PubMed ID: 17764465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
    Jazet IM; Pijl H; Frölich M; Romijn JA; Meinders AE
    Metabolism; 2005 Jun; 54(6):705-12. PubMed ID: 15931603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes.
    Hawkins M; Tonelli J; Kishore P; Stein D; Ragucci E; Gitig A; Reddy K
    Diabetes; 2003 Nov; 52(11):2748-58. PubMed ID: 14578293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute elevation of free fatty acids impairs hepatic glucose uptake in conscious rats.
    Nakahara I; Matsuhisa M; Shiba Y; Kuroda A; Nakatani Y; Hatazaki M; Kajimoto Y; Kubota M; Yamasaki Y; Hori M
    Diabetes Res Clin Pract; 2004 Nov; 66(2):109-18. PubMed ID: 15533577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of endogenous glucose production after a mixed meal in type 2 diabetes.
    Singhal P; Caumo A; Carey PE; Cobelli C; Taylor R
    Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E275-83. PubMed ID: 12110532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
    Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
    Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
    Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
    Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects.
    Hawkins M; Gabriely I; Wozniak R; Reddy K; Rossetti L; Shamoon H
    Diabetes; 2002 Jul; 51(7):2179-89. PubMed ID: 12086948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring.
    Anderwald C; Pfeiler G; Nowotny P; Anderwald-Stadler M; Krebs M; Bischof MG; Kozakova M; Luger A; Pacini G; Roden M; Waldhäusl W
    Eur J Clin Invest; 2008 Apr; 38(4):227-37. PubMed ID: 18339003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sequence variation in the mitochondrial glycerol-3-phosphate dehydrogenase gene is associated with increased plasma glycerol and free fatty acid concentrations among French Canadians.
    St-Pierre J; Vohl MC; Brisson D; Perron P; Després JP; Hudson TJ; Gaudet D
    Mol Genet Metab; 2001 Mar; 72(3):209-17. PubMed ID: 11243726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes.
    Basu R; Schwenk WF; Rizza RA
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E55-62. PubMed ID: 14982753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
    Boden G; Chen X
    Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated.
    Johnson NA; Stannard SR; Rowlands DS; Chapman PG; Thompson CH; Sachinwalla T; Thompson MW
    Diabet Med; 2006 Oct; 23(10):1061-8. PubMed ID: 16978369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.